Kidney Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have a kidney mass (lump or growth on the kidney) that requires surgery to remove part or all of the kidney
- You are enrolled in the French social security system
- You are willing and able to sign a consent form agreeing to take part
For the control group (comparison group):
- You are having a kidney removal that was not planned in advance (confirm with trial site)
- You are enrolled in the French social security system
- You are willing and able to sign a consent form agreeing to take part
Who may not be able to join:
- Your urine sample is too small — less than 100 ml cannot be collected
- You currently have a urinary catheter (a tube inserted to drain urine from the bladder)
- You are under a court-appointed legal guardianship or have a court-appointed curator managing your affairs
⚠️ Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Nicolas MOTTET, MD PhD, Centre Hospitalier Universitaire de Saint Etienne
Phone: (0)477828331
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of patients (with clear cell kidney cancer) with CD9+ and CA9+ exosomes by electron microscopy technique
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.